Karyopharm Therapeutics has reached a significant milestone by completing patient enrolment for its Phase III SENTRY trial.

Revolution will now explore daraxonrasib’s potential as a monotherapy and in combination with chemotherapy in late-stage PDAC ...

In August, Regeneron announced positive results from Phase III clinical trial NIMBLE evaluating the efficacy and safety of ...

PhaseV has entered into a strategic partnership with Bioforum to enhance the efficiency of clinical trials using advanced ...

These readouts will help Regeneron structure the confirmatory trials for the two allergy combination therapies.

Transformative new shifts have taken place in the last month in the metabolic dysfunction-associated steatohepatitis (MASH) ...

AstraZeneca's Tagrisso, in combination with pemetrexed and platinum-based chemotherapy, has shown a significant improvement ...

As the IASLC 2025 World Conference on Lung Cancer approaches, CTA looks at some of the most promising NSCLC assets in Phase ...

Sanofi’s stock dropped in the wake of data from its Phase III trial of atopic dermatitis (AD) candidate amlitelimab, which ...

Takeda’s readout comes from two pivotal Phase III trials of its OX2R, with Alkermes’ data coming from a Phase II trial in NT1 ...

Alnylam has disclosed new analysis findings from the HELIOS-B Phase III clinical trial of RNA interference (RNAi) therapeutic ...

In the real-world trial, Novo Nordisk's Wegovy showed a significant reduction in CV events compared to Eli Lilly’s Zepbound.